 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Mark Newbrough, MD, Assistant Professor - Medicine, University Health Associates, West Virginia University - Charleston Division, 3110 MacCorkle Avenue, SE, Charleston, WV 25304, 304-347-1342, mnewbrough@hsc.wvu.edu, Bruce Friedman, PhD, Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Avenue, Box 644, Rochester, NY 14642, William Barker, MD, Department of Community and Preventative Medicine, University of Rochester Medical Center, P.O. Box 644, Rochester, NY 14642, Gerald M. Eggert, PhD, Executive Director, Monroe County Long Term Care Program, Inc./ACCESS, 349 West Commercial Street, Suite 2250, East Rochester, NY 14445, and Brenda Wamsley, MSW, Executive Director, Center for Aging & Healthcare in West Virginia, 517 Market Street, Dils Building, Parkersburg, WV 26101.
Our objective is to compare the utilization of a number of primary and secondary disease prevention measures in three intervention groups (Health Promotion Nurse [HPN], Voucher, and HPN plus Voucher [Combination group]) versus the Control group in the "Medicare Primary and Consumer-Directed Care Demonstration." The purpose of the Demonstration is to test the acceptability and effectiveness of three models of consumer-directed care in a population of Medicare beneficiaries who are chronically disabled and at increased risk for hospitalization. Of the 1,609 participants who were randomly assigned to each of four groups (HPN, Voucher, Combination, and Control), about 1,000 are expected to complete the Demonstration. (Approximately 400 are expected to die and another 200 to drop out.) Data on a broad array of self-reported sociodemographic, health status, and empowerment/self-efficacy measures were collected at baseline and 22 months post-baseline. Also collected was data regarding the utilization of a number of primary and secondary disease prevention measures, including: vision and hearing screening; blood pressure and cholesterol measurement; immunizations including influenza, pneumococcal, and tetanus; and screening for colon, breast, and cervical cancer. Our hypothesis is that the three intervention groups will experience higher utilization of these prevention measures due to the greater empowerment/self-efficacy that is expected in these groups versus the Control group. Logistic regression analyses (controlling for any baseline differences in health status and other variables) will be performed to compare the utilization of these primary and secondary disease prevention measures for each group at baseline and at 22 months.
Learning Objectives:
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.